PTAB Axes Bulk Of Possible Cancer Treatment Patent In PGR
The Patent Trial and Appeal Board has invalidated the overwhelming majority of claims Hybrigenics SA challenged in a Forma Therapeutics Inc. patent for a potential cancer treatment for lack of written...To view the full article, register now.
Already a subscriber? Click here to view full article